X T L Biopharmaceuticals reported $166K in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Alaunos Therapeutics USD 1.52M 367K Jun/2026
Bioline Rx USD 33.48M 5.32M Jun/2026
Teva Pharmaceutical Industries USD 40.04B 185M Sep/2026
X T L Biopharmaceuticals USD 166K 548K Dec/2025